Full metadata record

DC Field Value Language
dc.contributor.authorJang, Mihue-
dc.contributor.authorHan, Hee Dong-
dc.contributor.authorAhn, Hyung Jun-
dc.date.accessioned2024-01-20T03:33:13Z-
dc.date.available2024-01-20T03:33:13Z-
dc.date.created2021-09-04-
dc.date.issued2016-08-26-
dc.identifier.issn2045-2322-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/123772-
dc.description.abstractIncorporating multiple copies of two RNAi molecules into a single nanostructure in a precisely controlled manner can provide an efficient delivery tool to regulate multiple gene pathways in the relation of mutual dependence. Here, we show a RNA nanotechnology platform for a two-in-one RNAi delivery system to contain polymeric two RNAi molecules within the same RNA nanoparticles, without the aid of polyelectrolyte condensation reagents. As our RNA nanoparticles lead to the simultaneous silencing of two targeted mRNAs, of which biological functions are highly interdependent, combination therapy for multi-drug resistance cancer cells, which was studied as a specific application of our two-inone RNAi delivery system, demonstrates the efficient synergistic effects for cancer therapy. Therefore, this RNA nanoparticles approach has an efficient tool for a simultaneous co-delivery of RNAi molecules in the RNAi-based biomedical applications, and our current studies present an efficient strategy to overcome multi-drug resistance caused by malfunction of genes in chemotherapy.-
dc.languageEnglish-
dc.publisherNATURE PUBLISHING GROUP-
dc.subjectMESOPOROUS SILICA NANOPARTICLES-
dc.subjectANTIAPOPTOTIC CELLULAR DEFENSE-
dc.subjectOVERCOME DRUG-RESISTANCE-
dc.subjectSINGLE-STRANDED RNA-
dc.subjectMULTIDRUG-RESISTANCE-
dc.subjectCO-DELIVERY-
dc.subjectIN-VITRO-
dc.subjectCANCER-CELLS-
dc.subjectDOXORUBICIN-
dc.subjectRECOGNITION-
dc.titleA RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy-
dc.typeArticle-
dc.identifier.doi10.1038/srep32363-
dc.description.journalClass1-
dc.identifier.bibliographicCitationSCIENTIFIC REPORTS, v.6-
dc.citation.titleSCIENTIFIC REPORTS-
dc.citation.volume6-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000381973800001-
dc.identifier.scopusid2-s2.0-84983753013-
dc.relation.journalWebOfScienceCategoryMultidisciplinary Sciences-
dc.relation.journalResearchAreaScience & Technology - Other Topics-
dc.type.docTypeArticle-
dc.subject.keywordPlusMESOPOROUS SILICA NANOPARTICLES-
dc.subject.keywordPlusANTIAPOPTOTIC CELLULAR DEFENSE-
dc.subject.keywordPlusOVERCOME DRUG-RESISTANCE-
dc.subject.keywordPlusSINGLE-STRANDED RNA-
dc.subject.keywordPlusMULTIDRUG-RESISTANCE-
dc.subject.keywordPlusCO-DELIVERY-
dc.subject.keywordPlusIN-VITRO-
dc.subject.keywordPlusCANCER-CELLS-
dc.subject.keywordPlusDOXORUBICIN-
dc.subject.keywordPlusRECOGNITION-
dc.subject.keywordAuthorsiRNA-
dc.subject.keywordAuthorDrug-resistance-
dc.subject.keywordAuthorgene silencing-
dc.subject.keywordAuthorovarian cancer-
Appears in Collections:
KIST Article > 2016
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE